206 related articles for article (PubMed ID: 9951496)
61. Perimetric progression using the Visual Field Index and the Advanced Glaucoma Intervention Study score and its clinical correlations.
Gros-Otero J; Castejón M; Paz-Moreno J; Mikropoulos D; Teus M
J Optom; 2015; 8(4):232-8. PubMed ID: 25182851
[TBL] [Abstract][Full Text] [Related]
62. The influence of the assessment method on the incidence of visual field progression in glaucoma: a network meta-analysis.
Ernest PJ; Viechtbauer W; Schouten JS; Beckers HJ; Hendrikse F; Prins MH; Webers CA
Acta Ophthalmol; 2012 Feb; 90(1):10-9. PubMed ID: 20942855
[TBL] [Abstract][Full Text] [Related]
63. Variability of automated visual fields in clinically stable glaucoma patients.
Werner EB; Petrig B; Krupin T; Bishop KI
Invest Ophthalmol Vis Sci; 1989 Jun; 30(6):1083-9. PubMed ID: 2732022
[TBL] [Abstract][Full Text] [Related]
64. Comparison of Methods to Detect and Measure Glaucomatous Visual Field Progression.
Rabiolo A; Morales E; Mohamed L; Capistrano V; Kim JH; Afifi A; Yu F; Coleman AL; Nouri-Mahdavi K; Caprioli J
Transl Vis Sci Technol; 2019 Sep; 8(5):2. PubMed ID: 31555493
[TBL] [Abstract][Full Text] [Related]
65. A model for quantitative assessment of visual field changes in primary open-angle glaucoma with a computerized perimeter DICON TKS 4000.
Atanassov M; Konareva-Kostianeva M
Folia Med (Plovdiv); 1998; 40(2):46-51. PubMed ID: 9707812
[TBL] [Abstract][Full Text] [Related]
66. Comparison of visual field severity classification systems for glaucoma.
Ng M; Sample PA; Pascual JP; Zangwill LM; Girkin CA; Liebmann JM; Weinreb RN; Racette L
J Glaucoma; 2012; 21(8):551-61. PubMed ID: 21878817
[TBL] [Abstract][Full Text] [Related]
67. Neural networks to identify glaucomatous visual field progression.
Lin A; Hoffman D; Gaasterland DE; Caprioli J
Am J Ophthalmol; 2003 Jan; 135(1):49-54. PubMed ID: 12504697
[TBL] [Abstract][Full Text] [Related]
68. [Perimetry of early glaucomatous visual fields defects. Comparative controlled study using the Goldman and Octopus perimeter].
Krieglstein GK; Schrems W; Gramer E; Leydhecker W
Buch Augenarzt; 1982; 90():23-33. PubMed ID: 7046882
[No Abstract] [Full Text] [Related]
69. Validation of the SITA faster strategy for the management of glaucoma.
Rodríguez-Agirretxe I; Loizate E; Astorkiza B; Onaindia A; Galdos-Olasagasti L; Basasoro A
Int Ophthalmol; 2022 Aug; 42(8):2347-2354. PubMed ID: 35072855
[TBL] [Abstract][Full Text] [Related]
70. [Gradation of visual field loss in glaucoma].
Wang XE
Zhonghua Yan Ke Za Zhi; 1990 May; 26(3):156-8. PubMed ID: 2397669
[TBL] [Abstract][Full Text] [Related]
71. Infrequent confirmation of visual field progression.
Lee AC; Sample PA; Blumenthal EZ; Berry C; Zangwill L; Weinreb RN
Ophthalmology; 2002 Jun; 109(6):1059-65. PubMed ID: 12045044
[TBL] [Abstract][Full Text] [Related]
72. Continuous visual field test supervision may not always be necessary.
Van Coevorden RE; Mills RP; Chen YY; Barnebey HS
Ophthalmology; 1999 Jan; 106(1):178-81. PubMed ID: 9917801
[TBL] [Abstract][Full Text] [Related]
73. Variability in glaucomatous visual fields: implications for shared care schemes.
Henson DB; Spry PG; Spencer IC; Sparrow JM
Ophthalmic Physiol Opt; 1998 Mar; 18(2):120-5. PubMed ID: 9692031
[TBL] [Abstract][Full Text] [Related]
74. [Is a medical treatment of glaucomatous field defects possible? Results of a double blind study (author's transl)].
Leydhecker W
Klin Monbl Augenheilkd; 1976 May; 168(05):631-6. PubMed ID: 785084
[TBL] [Abstract][Full Text] [Related]
75. A modified glaucoma staging system based on visual field index.
Hirasawa K; Shoji N; Morita T; Shimizu K
Graefes Arch Clin Exp Ophthalmol; 2013 Dec; 251(12):2747-52. PubMed ID: 24136631
[TBL] [Abstract][Full Text] [Related]
76. Relative risk of progressive glaucomatous visual field loss in patients enrolled and not enrolled in a prospective longitudinal study.
Henson DB; Shambhu S
Arch Ophthalmol; 2006 Oct; 124(10):1405-8. PubMed ID: 17030707
[TBL] [Abstract][Full Text] [Related]
77. Demographic, Comorbid, and Clinical Variables Associated With Pointwise Visual Field Damage in Glaucoma: Data From the AGIS and CIGTS Clinical Trials.
Gillespie BW; Niziol LM; Ehrlich JR; Johnson CA; Caprioli J; VanVeldhuisen PC; Lichter PR; Musch DC
Transl Vis Sci Technol; 2021 Oct; 10(12):28. PubMed ID: 34665232
[TBL] [Abstract][Full Text] [Related]
78. Correlation of quality of life with clinical symptoms and signs at the time of glaucoma diagnosis.
Mills RP
Trans Am Ophthalmol Soc; 1998; 96():753-812. PubMed ID: 10360308
[TBL] [Abstract][Full Text] [Related]
79. What reduction in standard automated perimetry variability would improve the detection of visual field progression?
Turpin A; McKendrick AM
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3237-45. PubMed ID: 21357405
[TBL] [Abstract][Full Text] [Related]
80. Determining progressive visual field loss in serial Humphrey visual fields.
Birch MK; Wishart PK; O'Donnell NP
Ophthalmology; 1995 Aug; 102(8):1227-34; discussion 1234-5. PubMed ID: 9097752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
